Evidence map›Paper›PMID 36029107›Full record

ArticleClinical genetics2022

A common intronic single nucleotide variant modifies PKD1 expression level.

Zhengmao Zhang, Jon Blumenfeld, Andrew Ramnauth, Irina Barash, Pengbo Zhou, Daniel Levine, Thomas Parker, Hanna Rennert

Open access · greenAbstract read
In one paragraph

Article in Clinical genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. RegulatingMolecular therapy. Nucleic acids · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhengmao ZhangDepartments of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Jon BlumenfeldDepartment of Medicine, Weill Cornell Medicine, New York, New York, USA.
Andrew RamnauthDepartments of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Irina BarashDepartment of Medicine, Weill Cornell Medicine, New York, New York, USA.
Pengbo ZhouDepartments of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Daniel LevineThe Rogosin Institute, New York, New York, USA.
Thomas ParkerThe Rogosin Institute, New York, New York, USA.
Hanna RennertDepartments of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Weill Cornell Medicine · USThe Rogosin Institute · US

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR002384
6 · The paper itself

Abstract

Autosomal dominant polycystic kidney disease (ADPKD), caused by mutations in PKD1 and PKD2 (PKD1/2), has unexplained phenotypic variability likely affected by environmental and other genetic factors. Approximately 10% of individuals with ADPKD phenotype have no causal mutation detected, possibly due to unrecognized risk variants of PKD1/2. This study was designed to identify risk variants of PKD genes through population genetic analyses. We used Wright's F-statistics (Fst) to evaluate common single nucleotide variants (SNVs) potentially favored by positive natural selection in PKD1 from 1000 Genomes Project (1KG) and genotyped 388 subjects from the Rogosin Institute ADPKD Data Repository. The variants with >90

Indexed as

Polycystic Kidney, Autosomal DominantTRPP Cation ChannelsHumansIntronsMutationNucleotidesRNA Splice SitesNucleotidesRNA Splice SitesTRPP Cation ChannelsADPKDhypomorphic variantintronnext-generation sequencingsingle nucleotide variant

Identifiers

PMID36029107
PMCPMC10947153
OpenAlexW4293368018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.